Financhill
Back

Intellia Therapeutics, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
23

NTLA
Intellia Therapeutics, Inc.

Last Price:
$9.41
Seasonality Move:
-6.88%
Sell
41

MNPR
Monopar Therapeutics, Inc.

Last Price:
$70.68
Seasonality Move:
25.93%
Sell
23
Intellia Therapeutics, Inc. (NTLA) is a Sell

Is Intellia Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Intellia Therapeutics, Inc. [NTLA] share price is $9.70. The Score for NTLA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $70.50. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics, Inc.'s stock price today?

  • The Intellia Therapeutics, Inc. share price today is $9.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight selling pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $70.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.64 Sell
Relative Strength Index (14 RSI): 47.92 Sell
Chaikin Money Flow: 1572788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.48 Sell
Relative Strength Index (14 RSI): 40.78 Sell
Chaikin Money Flow: -194871 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.3 - 85.58) Sell
Bollinger Bands (100): (46.5 - 89.48) Buy

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.18 Buy
20-day SMA: 9.04 Buy
50-day SMA: 13.02 Sell
200-day SMA: 11.33 Sell
8-day EMA: 9.23 Buy
20-day EMA: 9.47 Buy
50-day EMA: 11.34 Sell
200-day EMA: 12.84 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70.62 Sell
20-day SMA: 76.51 Sell
50-day SMA: 80.5 Sell
200-day SMA: 52.75 Buy
8-day EMA: 71.14 Sell
20-day EMA: 74.96 Sell
50-day EMA: 76.33 Sell
200-day EMA: 56.96 Buy

Intellia Therapeutics, Inc. Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.31 per share, and an increase next year of $0.38 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Intellia Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):